A bariatric device includes an esophageal member having an esophageal surface that is configured to generally conform to the shape and size of a portion of the esophagus and an anchoring technique anchoring the esophageal member to the portion of the esophagus. The bariatric device includes a cardiac member having a cardiac surface that is configured to generally conform to the shape and size of a portion of the cardiac portion of the stomach and a connector connected with the esophageal member and the cardiac member to cause strain to be applied by the cardiac member to the cardiac portion of the stomach. The strain applied by the cardiac member to the cardiac portion of the stomach causes satiety in the absence of food. The connector is adapted to pass through the gastroesophageal junction while leaving a continuous portion of the gastroesophageal junction substantially unrestrained.

For desorptive technique, inhibiting hunger and reducing the amount of food ingested, besides avoiding the contact of the food with part of the intestine, working for the weight reduction of the patient and associated diseases such as type 2 diabetes. For this, a gastrointestinal device (10) formed from an intragastric ring (1) made of malleable and expandable material, extends a tubular sleeve (3) with or without a stent. The gastrointestinal device (10) has its inlet valve (4) attached to a catheter (CA) for gastrointestinal implant, and is directed into the stomach (L) of the patient, where an endoscopic forceps (EP) or the stent directs the tubular sleeve (3) through the pyloric canal (P), into the duodenum (D), and unfolding until it occupies part of the intestine. Therefore, the intragastric ring (1) is positioned near the Pyloric canal (P), inside the stomach (E), and is then inflated and expanded by fluid—liquid, gas or air, assuming the shape of a balloon.

The present disclosure provides systems and devices for monitoring the pressure within a negative pressure system, such as a suction cannister. In one aspect, the system includes an anchor configured for positioning within an intestine of the patient at the anastomosis site and a source of negative pressure, such as a suction cannister, fluidly coupled to the anchor. A portable alarm device is coupled to the suction cannister and includes a trigger for detecting the pressure therein. A signal device emits a signal when this pressure is above a threshold level to ensure that the anchor remains securely in contact with the walls of the intestines at the anastomosis site. The alarm device includes a handle to allow a patient to grasp and carry the suction cannister, providing critical patient mobility during the recovery period.

A gastroplasty method involves a staple line that terminates prior to reaching the gastroesophageal junction such that the bypassed portion of the stomach does not require resection. Additionally, bougies are taught that assist a physician in following the improved staple line of the present invention.

A tissue wall of a biological lumen may be reinforced by embedding a material or structure into the tissue wall. The reinforcement material or structure may embed by application of outwardly directed force along an interior side of the tissue wall, threading, or injection. The reinforcement material or structure may act as an embedded scaffold that limits expansion or contraction of the tissue wall to pushing or pulling forces. An anchor device, such as a medical device, may anchor to the reinforced portion of the tissue wall.

The invention relates surgical abdominal methods of treating obesity in a patient by implanting a volume filling device that, when implanted in a patient, reduces the food cavity in size by a volume substantially exceeding the volume of the volume filling device. Also disclosed is a laparoscopic instrument for providing a volume filling device to be invaginated in the stomach wall of a human patient to treat obesity.

An apparatus for treating obesity comprises a volume filling device formed by at least two segments and is provided and following implantation, the device is placed resting against the stomach wall of the patient to reduce the inner volume of the stomach, thereby affecting the patients appetite.

An illustrative stent may include a tubular member defined by at least one knitted filament forming a plurality of twisted knit stitches with rungs extending circumferentially between radially adjacent twisted knit stitches, where each twisted knit stitch is interconnected with a longitudinally adjacent twisted knit stitch forming a series of linked stitches. The tubular member may be implanted to connect two spaced apart anatomical locations within the digestive tract, moving between a relaxed configuration and an elongated configuration. The tubular member has a first longitudinal length in the relaxed configuration and a second longitudinal length in the elongated configuration, and the first longitudinal length is less than the second longitudinal length.

A gastrointestinal device for treating obesity includes a three-dimensional porous structure configurable between a compressed pre-deployment configuration to facilitate delivery and an expanded post-deployment configuration. The porous structure includes a first opening at its proximal end and a larger second opening at its distal end. The porous structure also includes a sleeve coupled to its distal end. Optionally, the device further includes a suture at the proximal end of the wire mesh structure to facilitate retrieval and an anti-migration component positioned at the junction of the porous structure with the sleeve. The porous structure is deployed in a patient's stomach such that the anti-migration component sits proximal to the patient's pylorus and prevents migration of the entirety of the device into and through the pylorus. The sleeve extends through the pylorus, into the duodenum and ends in the duodenum or jejunum. Food enters the device from the first opening at the proximal end of the porous structure, passes through the porous structure and sleeve, and exits at the distal end of the sleeve. The device treats obesity by providing a relatively immovable volume occupying structure in the stomach and a bypass for food past the pylorus and proximal portion of the small intestine. Optionally, the device further acts to slow the passage of food through the digestive tract. Patients with the device experience satiety more quickly and have a prolonged sensation of satiety.

A stomach lining patch includes a collapsible frame, a membrane covering the collapsible frame, collapsible frame and the membrane providing a collapsed configuration suitable for endoluminal delivery to a stomach of a patient and an expanded configuration suitable for lining an internal surface of a gastric wall of the stomach, and a set of anchoring arms extending from the collapsible frame and being configured to pass through a puncture in the gastric wall and lay flat against an outer surface of the gastric wall when the collapsible frame and the membrane are in an expanded configuration lining the internal surface of the gastric wall.